Controversies in cardiovascular medicine: Chronic stable coronary artery disease: drugs vs. revascularization.
about
Therapeutic impact of follistatin-like 1 on myocardial ischemic injury in preclinical modelsAntiplatelet therapy for patients with stable ischemic heart disease and baseline thrombocytopenia: ask the hematologist.Revascularisation versus medical treatment in patients with stable coronary artery disease: network meta-analysis.Diagnostic and prognostic value of absence of coronary artery calcification in patients with stable chest symptoms.Performance of the 2-hour accelerated diagnostic protocol within the American College of Radiology Imaging Network PA 4005 cohortTotal saponins from Aralia taibaiensis protect against myocardial ischemia/reperfusion injury through AMPK pathway.Determinants of variations in initial treatment strategies for stable ischemic heart disease.Performance of the EDACS-accelerated Diagnostic Pathway in a Cohort of US Patients with Acute Chest Pain.Long-term prognostic value of exercise technetium-99m tetrofosmin myocardial perfusion single-photon emission computed tomography.Women and men with stable coronary artery disease have similar clinical outcomes: insights from the international prospective CLARIFY registry.Coronary artery disease: to cath or not to cath? When and how best to cath: those are the remaining questions.Relation between initial treatment strategy in stable coronary artery disease and 1-year costs in Ontario: a population-based cohort studyProtective effects of low-frequency magnetic fields on cardiomyocytes from ischemia reperfusion injury via ROS and NO/ONOO-.Antianginal Efficacy of Ivabradine in Patients With History of Coronary Revascularization.Therapeutic strategies in patients with chronic stable coronary artery disease.Imaging as an End Point in Ischemia Trials.Stable angina pectoris: antianginal therapies and future directions.Ten-year trends in the use of catheter ablation for treatment of atrial fibrillation vs. the use of coronary intervention for the treatment of ischaemic heart disease in Australia.Antagonist molecules in the treatment of anginaClinical effect of cardiac shock wave therapy on patients with ischaemic heart disease: a systematic review and meta-analysis.NAF-1 antagonizes starvation-induced autophagy through AMPK signaling pathway in cardiomyocytes.Impact of ischemia and scar on therapeutic benefit of myocardial revascularization.ESC core curriculum for the general cardiologist (2013).Optimal timing for first-pass stress CT myocardial perfusion imaging.Low body weight and clinical outcomes in acute coronary syndrome patients: results of the ACHILLES Registry.miR-126 in Peripheral Blood Mononuclear Cells Negatively Correlates with Risk and Severity and is Associated with Inflammatory Cytokines as well as Intercellular Adhesion Molecule-1 in Patients with Coronary Artery Disease.Evaluating the prognostic value of positron-emission tomography myocardial perfusion imaging using automated software to calculate perfusion defect size.Management and clinical outcome of stable coronary artery disease in Austria : Results from 5 years of the CLARIFY registry.Effect of percutaneous coronary intervention on quality of life: a consensus statement from the Society for Cardiovascular Angiography and Interventions.Correlation Clustering of Stable Angina Clinical Care Patterns for 506 Thousand Patients.Ready for a Risk Stratification Robot?Use of the HEART Pathway with high sensitivity cardiac troponins: A secondary analysis.Deciding on coronary intervention: which lesion, which stent?Resting Myocardial Contrast Echocardiography for the Evaluation of Coronary Microcirculation Dysfunction in Patients With Early Coronary Artery Disease.Treating stable angina - is there a NICE way towards an international consensus?CABG and Preoperative use of Beta-Blockers in Patients with Stable Angina are Associated with Better Cardiovascular Survival.
P2860
Q28273799-05757B3D-44EB-4A77-B691-EC595D0FF3A5Q33410598-DF3BA556-5766-43F5-AC24-D6B4AAF738EBQ33791885-BEC06856-9644-4051-835A-871CC6572C9CQ34918355-25D44FDC-842E-4C58-9DB5-372B070A7337Q35510118-53EAA4BF-6540-450F-BB90-BFFBBDC61EE8Q35820226-03262CE3-B838-4BEB-A4E9-10770EA3FD59Q35847120-81FBA5A8-9EE7-43B7-82B5-BAC085DC1098Q36289270-08814B17-E3AE-49B3-8432-093E78C42ED8Q36291507-7C77A3C4-98CF-4A9D-9162-F591FA0D1841Q36398736-7D40C3CE-CFA5-46D8-A21D-9B9538E75C0CQ36645771-66309839-F3DE-4602-90E4-418E84A90F5CQ37306197-6360A0E9-EEB7-4028-969D-1F65FF303CC3Q37339229-9B2E215A-C4F2-41E5-B3AE-67C43785A6A0Q37495266-D72DE8E0-C529-46BC-9AA9-695CD54E9515Q37759029-4B6D94AA-FF28-48A5-BEAA-74E1C0B47DE8Q37863002-B688D016-3E57-4744-B0A0-8DF39F25BC6DQ37924086-D2940E92-67CB-4A8D-BBF4-1E8E2A577DEBQ38116666-57AF8EFA-EF0B-4A55-A4D4-7798E3FFB6E0Q38139089-E7D9F8EF-0497-4A18-9581-36412FA26A90Q38601379-401EAA25-B4BD-4DF6-A385-CA7BFFB6AD43Q41415358-47AA0B52-24CD-462C-8F36-0FB15BCBBCFBQ42596977-7BDD2273-2743-4705-B03E-587667EB676EQ43464217-A1EFE4F0-83F7-439C-AEF3-148BA7F6B232Q45812677-69056BAE-CEC3-43DA-93C3-C04C138433E4Q47213003-B54A6934-718A-4823-BA75-7BA4C28D6DB3Q47217231-BC5F3FFA-0DE7-4A94-B927-2D92BE8ACADDQ47286597-14326ABB-4864-451D-B438-63B6884383F0Q47681086-A49DAAC5-83F1-4727-BCF7-7CA8C8BF05BFQ48002756-55ECAC7F-6961-492B-B022-7B2244926A84Q48214344-595FC23C-95F1-4C76-B95E-C4107F6152C1Q50622985-10E6EFBC-DBD4-418F-8990-88FEA621ECD7Q51191658-7A1D25BB-D4B2-417E-A1B9-96BAF22D8A3FQ51606447-CC3D78AE-8642-4E0A-8BDF-C8B9BD41CD80Q52983055-4673550D-4A29-48D9-AF91-9DB83040F940Q53128488-3CB236EC-17B2-4D2D-A85B-973FDA86396EQ55075663-5851EC63-2C7F-4DF3-A7B2-B8CEB5A7F2F0
P2860
Controversies in cardiovascular medicine: Chronic stable coronary artery disease: drugs vs. revascularization.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 26 January 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Controversies in cardiovascula ...... : drugs vs. revascularization.
@en
Controversies in cardiovascula ...... : drugs vs. revascularization.
@nl
type
label
Controversies in cardiovascula ...... : drugs vs. revascularization.
@en
Controversies in cardiovascula ...... : drugs vs. revascularization.
@nl
prefLabel
Controversies in cardiovascula ...... : drugs vs. revascularization.
@en
Controversies in cardiovascula ...... : drugs vs. revascularization.
@nl
P2860
P356
P1476
Controversies in cardiovascula ...... : drugs vs. revascularization.
@en
P2860
P304
P356
10.1093/EURHEARTJ/EHP605
P577
2010-01-26T00:00:00Z